• 제목/요약/키워드: NMDA(N-methyl-D-asparate)

검색결과 2건 처리시간 0.014초

NMDA(N-methyl-D-asparate)의 투여에 의해 유발된 신경 과흥분상태에서의 쥐의 뇌조직 변화 (Histological changes in brain tissue of rat induced neuronal excitotoxicity by NMDA(N-methyl-D-asparate))

  • 송재찬
    • 대한수의학회지
    • /
    • 제38권2호
    • /
    • pp.290-296
    • /
    • 1998
  • Histological changes was investigated in the 4 weeks old rat brain using NMDA (N-methyl-D-asparate) which is capable of mediating excitotoxic events. The changes were occured when the injected NMDA solved in PBS was over $1.0{\mu}g/g$(about 90nM). The necrosis of Purkinje cells in cerebellum and the increasement of coloidal plexus cell number were prevalent. The Purkinje cell number of necrosis were increased according to increasement of amount of injected NMDA. In spite of increasement of degenerated Purkinje cell number, differentiation of new Purkinje cell was not identified because total number of Purkinje cell was not changed. The change of cell number was observed in coloidal plexus cell rather than degeneration of cell. About 5 time increasement was occured. This change may cause increasement of cerebrospinal fluid and the makes mophorogy of brain more round than nomal.

  • PDF

Mammalian Target of Rapamycin 신호전달체계와 우울증 (Mammalian Target of Rapamycin Signaling Pathways and Depression)

  • 이정구;서미경;박성우;김영훈
    • 생물정신의학
    • /
    • 제23권1호
    • /
    • pp.18-23
    • /
    • 2016
  • Depression is a complicated psychiatric illness with severe consequences. Despite recent advanced achievements of molecular neurobiology, pathophysiology of depression has not been well elucidated. Among new findings of pathophysiology of depression, the possible fast antidepressant effect by N-methyl-D-asparate receptor antagonist, such as ketamine, is regarded as a promising treatment target of depression. Ketamine stimulates the mammalian target of rapamycin (mTOR) signaling pathway and activation of mTOR signaling pathway may be a key mechanism of the antidepressant effect of ketamine. Thus, this review describes the role of mTOR signaling in the pathophysiology of depression and developing a new treatment target of depression.